RT @SRAnesthesiaICU: We collected all available RCTs on #tocilizumab and confirmed that IL-6 inhibitors reduced longest follow-up mortality…
RT @SRAnesthesiaICU: We collected all available RCTs on #tocilizumab and confirmed that IL-6 inhibitors reduced longest follow-up mortality…
RT @SRAnesthesiaICU: We collected all available RCTs on #tocilizumab and confirmed that IL-6 inhibitors reduced longest follow-up mortality…
RT @SRAnesthesiaICU: We collected all available RCTs on #tocilizumab and confirmed that IL-6 inhibitors reduced longest follow-up mortality…
RT @SRAnesthesiaICU: We collected all available RCTs on #tocilizumab and confirmed that IL-6 inhibitors reduced longest follow-up mortality…
RT @SRAnesthesiaICU: We collected all available RCTs on #tocilizumab and confirmed that IL-6 inhibitors reduced longest follow-up mortality…
We collected all available RCTs on #tocilizumab and confirmed that IL-6 inhibitors reduced longest follow-up mortality (28% vs 24%) and intubation in #COVID19 patients. 🔗 https://t.co/F5sh3rw001 #FOAMcc https://t.co/uo91tfThA0
RT @of_aic: IL-6 inhibitors reduced longest follow-up mortality and intubation in COVID-19 patients. Findings need to be confirmed in high-…
IL-6 inhibitors reduced longest follow-up mortality and intubation in COVID-19 patients. Findings need to be confirmed in high-quality RCTs. 🔗https://t.co/wwPLf44lCW @AlessandroBelletti #COVID-19 #IL-6 #Mortality #SRLF #FICS #AIC https://t.co/e4EPpOajVn
RT @KGHNHSLibrary: Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of mul…
RT @KGHNHSLibrary: Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of mul…
Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials https://t.co/76n3fis0fG
RT @qgorgas: Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis https://t.c…
Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis https://t.co/90vGhZrHLe
Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials https://t.co/WxcpH0OuMf
IL-6 Inhibs https://t.co/grPEYqRW9w https://t.co/YPq4COPL5I
6-24-2021: Italy has 26 of the world's 189 pro-Actemra COVID-19 studies and 0 of the world's 5 pro-Actemra pro-IL6-blocking meta-analyses (Angriman, Coomes, Mojtabavi, Tharmarajah, Meanwatthana). Alessandro Belletti has become Italy's 1st, world's 6th: h
Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials | Annals of Intensive Care | https://t.co/ZC3CBfjFNb